Choosing a Medical Marijuana Strain: What Determines the Description and What the Batch Documentation Says
Criteria for choosing a strain in order: trade name, declared content, terpene profile, and method of administration compared to what is actually stated in the documentation of a specific batch. No ranking and no list of available items.
What does the choice of strain start with, if not the name?
The choice of a medical marijuana strain rarely comes down to the brand. It is determined by the composition declared for a specific batch, the named symptom that is to be alleviated, and the form in which the raw material will be administered. The trade name is a label for this set, not its cause, and does not tell you what will be in the package issued at the pharmacy.
Hemp flower is available in Poland only by prescription from a doctor, in the Rpw category. The prescription states the name of the specific product along with the quantity and method of use, and the pharmacy dispenses exactly what is written. Switching to another raw material requires a new document, not a conversation at the counter. Therefore, the choice of strain is practically a preparation for a conversation in the office, not a decision made in front of the shelf. The entire process from the visit to the prescription fulfillment is described in a separate text about the process of obtaining a prescription for medical marijuana.
This leads to the order in which this text lays out the criteria. First, the symptom named as narrowly as possible, then the composition described in the batch documentation, then the method of administration, and only at the end the trade name, which summarizes all four with one word. The reverse path, from name to symptom, can lead to disappointment: the patient receives the raw material they requested and does not get an answer to the problem they came with.
You will not find a ranking or a list of available items here. The assortment changes with the rhythm of deliveries and permits, so the state as of today is only in the list of medical marijuana strains, which we refresh separately. Here, only the criteria remain, as they age more slowly than the list of names.
What cannot be read from the strain description?
Three things: what exactly will be in the package, how this batch differs from the previous one, and where the numbers next to the name come from. The description summarizes the breeding and commercial material, while the document describing the specific raw material remains the batch analysis, which the manufacturer performs for each batch before it is put on the market.
The same name from two manufacturers does not mean the same material. A plant grown in two facilities differs in growing conditions, harvest time, and drying method, and each of these things changes the composition of the finished raw material. The trade name is not a concept protected in a way that would enforce consistency of composition between manufacturers. It is a hallmark of the breeding line, not a specification.
| What the strain description carries | What the batch documentation corresponds to |
|---|---|
| trade name and lineage of the line | batch number and manufacturer responsible for it |
| general description of aroma and sensations | indication of active substance content for this batch |
| terpene profile transcribed from the database | result of microbiological purity testing |
| type of plant label | expiration date and storage conditions |
The division between these columns is practical, not academic. The description helps to understand why two raw materials may be perceived differently, while the question of what you have in hand is resolved solely by the documentation attached to the issued batch. This is what you ask the pharmacist about, not the author of the article. It is worth remembering this especially for new items in the list, whose description online was created before the first delivery to a Polish pharmacy and may be a translation of the breeder’s material from another market.
What does the declared content of active substances mean?
It means the value applicable to the batch, not a constant feature of the strain. The declaration has a tolerance of up to ten percent of the value, so an item described as twenty percent actually falls between eighteen and twenty-two. One number assigned to the name inflates precision by an order of magnitude and is often read as a measurement.
Therefore, in this service, we provide the content as a range, not a single number. The range is not a sign of the author’s uncertainty, but a faithful record of what the manufacturer declares: nominal value plus allowed tolerance. Additionally, there is variability between manufacturers offering the same name, so two items with identical descriptions can differ by several points.
A higher content does not mean a better raw material, just a stronger one, and that is not the same. The ratio between the two main active substances describes the chemotype and tells more about the material than the name: some items have a THC advantage, others contain both substances side by side, while others are based on cannabidiol. Where the differences in potency come from and why the number on the label can be misleading is broken down in the entry about what affects the potency of marijuana. The dose and the rate of its increase are determined by the doctor on the prescription, and that record is what counts, not the number printed on the package.
How much does the terpene profile tell you once you find it?
Less than commercial descriptions promise. The profile organizes the conversation about how two raw materials with similar active substance content differ in perception, but does not predict the outcome of therapy. It is also often provided incorrectly: two Polish databases describing the same strains often disagree on the composition.
This inconsistency is measured, not assumed. Of the twenty-four strains described by both sources, the composition agrees in three and differs in twenty-one. This is not a data flaw, but a state of the market, where the profile is often transcribed from the breeder’s material instead of from the batch analysis. Anyone comparing two tables from two services is most often comparing two different source materials, not two strains.
We do not provide percentage shares anywhere in this cluster, and there is a measured reason for that. Sum the shares from one database, then from the other, and you will get two different wholes, and neither will reach completeness. A percentage without a stated basis is not a measurement, but a number with an unclear reference. Such a number looks serious in a text about a drug and that is why it is misleading: it suggests a measurement where none was conducted.
The status of evidence is also worth knowing before the profile becomes a criterion. What is known about individual terpenes comes from review articles and preclinical models, not from studies on patients taking the named pharmaceutical raw material. We dedicate a separate text to myrcene, the most frequently indicated dominant terpene in this list, and the way to read the entire description is broken down in the guide to the cannabis strain profile.
Why does the method of administration weigh more than the name itself?
Because it determines when the effect appears and how long it lasts, and these two things are influenced by the strain to a much lesser extent. After vaporization, the onset of action occurs within the first minutes. After oral administration, it is delayed by half an hour to two hours, as the substance passes through the digestive tract and liver first.
The peak and duration also differ. With vaporization, the peak occurs after ten to thirty minutes, and the entire effect lasts two to four hours. After oral administration, the peak shifts to the second or third hour, and the effect can last even several times longer than the onset, up to six or eight hours. This leads to the typical mistake of the first oral dose: a second dose taken out of impatience overlaps with the first.
A symptom that increases at night leads to a different form than a symptom that appears suddenly during the day, and this distinction is worth bringing to the visit along with a description of the ailments. Vaporization requires equipment designed for pharmaceutical raw material and temperature settings, as it depends on which compounds will actually vaporize. Smoking flower is not a method of administering the drug, as it does not allow for dose replication. The relationship between the device settings and the material in the chamber is broken down in a separate text about vaporizing flower.
Where to check which strains are currently available?
In two places, neither of which is this article. The first is the list of strains present in Polish pharmacies maintained by us, the second is the Register of Medicinal Products on the side of the Office for Registration of Medicinal Products. A text read six months after writing would provide a state that no one could confirm.
The list currently includes eighty-five cultivars supplied by sixteen manufacturers, and it answers the question of what is on the market, as well as which manufacturer is responsible for a given item. You can find it at the list of medical marijuana strains. We do not provide prices in this text, as they age faster than anything else and also stand only in the list.
However, approval for sale does not mean that the raw material is sitting on the shelf. There are few pharmacies that handle controlled substances, stocks deplete unevenly, and the wholesaler serving a given pharmacy may be different from the one that has the item in stock. A phone call before the visit saves a second trip around the city. The reason why the number of available items fluctuates from month to month is explained in the entry about which medical marijuana strains are available in Poland.
What does this text not resolve?
It does not say which strain is better, and it does not indicate the raw material for a specific indication. There are no studies comparing named cultivars among patients, so any such ranking is based on commercial descriptions and anecdotes, not on data. The decision rests with the doctor issuing the prescription.
What remains, however, is something the patient prepares themselves: a description of their own symptoms. Which ailments are to be alleviated, at what time of day they intensify, what medications you take regularly, whether you drive vehicles. The note “pain increases after eight PM and wakes me up at night” carries information that a request for something for pain does not contain, and simultaneously narrows down the chemotype and method of administration.
Outside the scope of this text are also side effects and interactions. Reports are collected for the medicinal product, not for the strain name, so the description of a single cultivar is not a place where they can be reliably assigned. Interactions depend on the complete list of medications taken, not on what the plant contains. The material is for informational purposes and does not replace medical advice or a conversation with a pharmacist.
Frequently Asked Questions about Choosing a Strain
Can you choose a strain yourself at the pharmacy?
No. The raw material is dispensed only on a Rpw prescription, on which the doctor writes the specific product, quantity, and method of use, and the pharmacist has no right to dispense another. A switch requires a new prescription.
Is there the best strain of medical marijuana?
There is no basis for claiming that. No one has compared named cultivars among patients, so the strain ranking is based on commercial materials and anecdotes, not on studies.
Why do you not provide percentage shares of terpenes?
Because sources do not provide a denominator. The sums of shares published for the same items are sometimes forty-six, sometimes seventy-three, sometimes eighty-three percent, so the number would look like a measurement, which it is not.
Why do you provide the content as a range, not a single number?
Because the tolerance for the declared value reaches ten percent, and versions from different manufacturers differ from each other. A single number would inflate precision by an order of magnitude.
Does the strain description replace the batch documentation?
No. The description pertains to the breeding line, while the documentation pertains to the batch you have in hand. Only the latter states what the content of active substances is in the issued package.
Where to check which strains are currently available?
In the list of strains maintained by this service and in the Register of Medicinal Products. However, approval for sale does not mean availability in a specific pharmacy, so it is worth calling before the visit.
Editorial text: ubucha.pl editorial team. Hemp flower is a pharmaceutical raw material dispensed by prescription from a doctor in the Rpw category. The material is for informational purposes and does not replace medical advice.
